Corbus Pharmaceuticals Holdings Inc.

02/08/2024 | Press release | Archived content

XBRL Q2 2024

Quarterly report pursuant to Section 13 or 15(d)

Cover

Cover - shares

6 Months Ended

Jun. 30, 2024

Aug. 02, 2024

Cover [Abstract]
Document Type 10-Q
Amendment Flag false
Document Quarterly Report true
Document Transition Report false
Document Period End Date Jun. 30, 2024
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-37348
Entity Registrant Name Corbus Pharmaceuticals Holdings, Inc.
Entity Central Index Key 0001595097
Entity Tax Identification Number 46-4348039
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 500 River Ridge Drive
Entity Address, City or Town Norwood
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02062
City Area Code (617)
Local Phone Number 963-0100
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CRBP
Security Exchange Name NASDAQ
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 12,043,940